Journal profile · Substance Abuse
Journal of Addiction Medicine
ISSN 1932-0620 · eISSN 1935-3227 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Quarterly · Founded 2007
Journal of Addiction Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.03; JCR Q2 (journal website); hybrid open access; median 120 days to acceptance (86 articles, last 24 months); community-reported acceptance: fairly easy; 200 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Addiction Medicine is published by Lippincott Williams and Wilkins Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes and HIV, Drug Use, Sexual Risk, together about 56.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Injection-related infections (IRI) are common and often require treatment with prolonged intravenous antibiotics via outpatient parenteral antimicrobial therapy (OPAT). However, patients with substance use disorders (SUD) being treated for IRI with OPAT receive suboptimal postdischarge care. We describe a novel program to co-locate OPAT and SUD supports at skilled nursing facilities (SNFs) in a pilot program to improve clinical outcomes.
From the journal's Aims & Scope
Research area (LetPub): Substance Abuse
Editor-in-chief David A. FiellinPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Opioid Use Disorder TreatmentMedicine25.8%
- Substance Abuse Treatment and OutcomesMedicine21.2%
- HIV, Drug Use, Sexual RiskMedicine9.2%
- Prenatal Substance Exposure EffectsMedicine6.5%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics5.5%
- Pain Management and Opioid UseMedicine4.2%
- Alcoholism and Thiamine DeficiencyMedicine3%
- Smoking Behavior and CessationMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Substance Abuse | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · SUBSTANCE ABUSE · rank 16/61
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.03LetPub ·
- Impact factor (publisher)
- 3.1Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 1.32LetPub ·
- SNIP 2026-06
- 1.11LetPub ·
- h-index
- 35LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 881OpenAlex ·
- 2-year mean citedness
- 2.23OpenAlex ·
- Self-citation rate
- 6.5%LetPub ·
- Share of gold OA articles
- 12.22%LetPub ·
Volume
- Articles per year
- 112LetPub ·
Articles by year OpenAlex count · 2,122 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 141 | 50 | 41 |
| 2025 | 200 | 75 | 300 |
| 2024 | 178 | 79 | 817 |
| 2023 | 134 | 66 | 1,240 |
| 2022 | 177 | 82 | 1,684 |
| 2021 | 146 | 78 | 2,438 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
120 daysMedian, submission to acceptance · P25–P75 90 days – 153 days
- Acceptance to online
- median 30 days (86 articles)
- Submission to online
- median 157 days
- Sample
- 86 articles with submission and acceptance dates (394 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2007
- ISSN
- 1932-0620
- Electronic ISSN
- 1935-3227
- Latest issue on the website
- Volume 20, Issue 4 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Addiction Medicine
What CAS zone is Journal of Addiction Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Addiction Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Addiction Medicine?
The latest impact factor listed by LetPub is 3.03; CiteScore 5.8, h-index 82.
How long does peer review take at Journal of Addiction Medicine?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 90–153 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Addiction Medicine in?
The journal's website gives JCR Q2; by category, SUBSTANCE ABUSE Q2 (16/61). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Which databases index Journal of Addiction Medicine?
According to LetPub and DOAJ records, Journal of Addiction Medicine is indexed in SCIE and Scopus.
Is Journal of Addiction Medicine open access, and what is the APC?
Journal of Addiction Medicine is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .